Перейти к содержанию

agilon health, inc. (AGL) stock: revenue, earnings & dividend

agilon health, inc. (AGL, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener AGL · NYSE Gesundheitswesen US-OH

Key figures

Fiscal year
2025
Revenue
5.93 bn $
Revenue growth
-2.1 %
Revenue growth 5y (p.a.)
37.2 %
Net income
-391.35 m $
Net margin
-6.6 %
Operating margin
-7.8 %
Earnings per share (diluted)
–
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
1.27 bn $
Equity
127 m $
Equity ratio
10 %
Return on equity
-308.8 %
Cash
174 m $
Operating cash flow
-105.76 m $
Free cash flow
-119.01 m $
Shares outstanding
16,795,774

History

Revenue by fiscal year

2019 794 m $
2020 1.22 bn $
2021 1.52 bn $
2022 2.39 bn $
2023 4.32 bn $
2024 6.06 bn $
2025 5.93 bn $

Net income by fiscal year

2019 -282.59 m $
2020 -60.05 m $
2021 -406.49 m $
2022 -106.55 m $
2023 -262.6 m $
2024 -260.15 m $
2025 -391.35 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20255.93 bn $-391.35 m $––-105.76 m $
20246.06 bn $-260.15 m $––-57.78 m $
20234.32 bn $-262.6 m $––-156.2 m $
20222.39 bn $-106.55 m $––-130.81 m $
20211.52 bn $-406.49 m $––-148.16 m $
20201.22 bn $-60.05 m $––-53.2 m $
2019794 m $-282.59 m $––-103.86 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)